These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24205533)

  • 21. Molecular diagnosis of myeloproliferative neoplasms.
    Patnaik MM; Tefferi A
    Expert Rev Mol Diagn; 2009 Jul; 9(5):481-92. PubMed ID: 19580432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular diagnosis of hematologic neoplasms].
    Lin Y; Ru K
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):612-4. PubMed ID: 26705191
    [No Abstract]   [Full Text] [Related]  

  • 23. Population-based incidence of myeloid malignancies: fifteen years of epidemiological data in the province of Girona, Spain.
    Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Lloveras N; Marcos-Gragera R
    Haematologica; 2013 Aug; 98(8):e95-7. PubMed ID: 23812933
    [No Abstract]   [Full Text] [Related]  

  • 24. [Introduction to the molecular diagnostic methods of oncohematology].
    Király AP; Alpár D; Fésüs V; Marosvári D; Matolcsy A; Bödör C
    Magy Onkol; 2016 Jun; 60(2):88-98. PubMed ID: 27275635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal residual disease in hematological malignancies.
    Raanani P; Hochhaus A
    Acta Haematol; 2004; 112(1-2):5-7. PubMed ID: 15178998
    [No Abstract]   [Full Text] [Related]  

  • 26. The incidence of co-existing BCR-ABL1 and JAK2 V617F rearrangements: implications for molecular diagnostics.
    McCarron SL; Haslam K; Crampe M; Langabeer SE
    Lab Hematol; 2012 Dec; 18(4):20-1. PubMed ID: 23253862
    [No Abstract]   [Full Text] [Related]  

  • 27. Prognostic significance of del(20q) in patients with hematological malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular genetic methods in the diagnosis of hematologic neoplasms.
    Sen F; Vega F; Medeiros LJ
    Semin Diagn Pathol; 2002 May; 19(2):72-93. PubMed ID: 12036283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indications and diagnostic utility of bone marrow examination in different bone marrow disorders in Iran.
    Mirzai AZ; Hosseini N; Sadeghipour A
    Lab Hematol; 2009; 15(4):38-44. PubMed ID: 19923104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase.
    Cherington C; Slack JL; Leis J; Adams RH; Reeder CB; Mikhael JR; Camoriano J; Noel P; Fauble V; Betcher J; Higgins MS; Gillette-Kent G; Tremblay LD; Peterson ME; Olsen JJ; Tibes R; Mesa RA
    Leuk Res; 2012 Sep; 36(9):1147-51. PubMed ID: 22578777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular diagnosis of hematopoietic and lymphoid neoplasms.
    Jevremovic D; Viswanatha DS
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):903-33. PubMed ID: 19577174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular diagnostic cytopathology: definitions, scope and clinical utility.
    Salto-Tellez M; Koay ES
    Cytopathology; 2004 Oct; 15(5):252-5. PubMed ID: 15456412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modern diagnostics in chronic myeloproliferative diseases (CMPDs).
    Haferlach T; Kern W; Schnittger S; Schoch C
    Ann Hematol; 2004; 83 Suppl 1():S59-61. PubMed ID: 15124674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoplastic hematopathology. Preface.
    Gascoyne RD
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):xi-xii. PubMed ID: 19577161
    [No Abstract]   [Full Text] [Related]  

  • 35. Flow cytometric diagnosis of myelodysplasia and myeloproliferative disorders.
    Wood BL
    J Biol Regul Homeost Agents; 2004; 18(2):141-5. PubMed ID: 15471218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular diagnostics].
    Hino M
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():188-92. PubMed ID: 23133950
    [No Abstract]   [Full Text] [Related]  

  • 37. International Consensus Classification for myeloid neoplasms at-a-glance.
    Orazi A; Hasserjian RP; Cazzola M; Döhner H; Tefferi A; Arber DA
    Am J Hematol; 2023 Jan; 98(1):6-10. PubMed ID: 36314608
    [No Abstract]   [Full Text] [Related]  

  • 38. [A prospect of genetic tests].
    Watanabe N
    Rinsho Byori; 2003 Jun; Suppl 126():139-44. PubMed ID: 12905954
    [No Abstract]   [Full Text] [Related]  

  • 39. The need for United States-based guidelines for myeloproliferative neoplasms.
    Stein BL; O'Brien S; Greenberg P; Mesa RA
    J Natl Compr Canc Netw; 2015 May; 13(5):607-9. PubMed ID: 25964644
    [No Abstract]   [Full Text] [Related]  

  • 40. Philadelphia chromosome-negative chronic myeloproliferative disease.
    Thiele J
    Am J Clin Pathol; 2009 Aug; 132(2):261-80. PubMed ID: 19605821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.